Xia, Z., Xu, Q., Cheng, S., Xu, P., Zhao, W. L., Li, W. (2025). Zanubrutinib, rituximab, and high-dose methotrexate as first-line treatment in newly diagnosed primary central nervous system lymphoma (zana): A prospective, single-arm study. Blood. https://doi.org/10.1182/blood-2025-60